Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuhlmann

Showing results (21-30 of 2,487) with videos related to

Pageof 249
Sort By:
Ernst Schering Research Foundation Workshop|November 23, 2006
The applications of biomarkers in early clinical drug development to improve decision-making processesJ Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1999
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Psychiatrische Praxis|July 1, 1996
[Harm reduction--on the paradigm changes in drug dependence treatment]T Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
ALTEX|January 1, 1993
[Problems of the prophylactic use of antibiotics in cell culture]Ingrid Kuhlmann
Clinical Pharmacology and Therapeutics|February 1, 1985
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxinJ Kuhlmann
Morphologie : Bulletin De L'Association Des Anatomistes|December 7, 2007
[The first ray of the hand and the foot of the primates (I). Descriptive anatomy]Norbert Kuhlmann
Cytotechnology|February 24, 2012
The prophylactic use of antibiotics in cell cultureI Kuhlmann
Journal of AOAC International|April 18, 2019
2-Monochloropropanediol (2-MCPD), 3-Monochloropropanediol (3-MCPD), and Glycidol in Infant and Adult/Pediatric Nutritional Formula: Single-Laboratory Validation, First Action 2018.12Jan Kuhlmann
Arzneimittel-Forschung|January 1, 1982
Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapyJ Kuhlmann
Pageof 249

Showing results (21-30 of 2,487) with videos related to

Sort By:
Pageof 249
Ernst Schering Research Foundation Workshop|November 23, 2006
The applications of biomarkers in early clinical drug development to improve decision-making processesJ Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1999
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Psychiatrische Praxis|July 1, 1996
[Harm reduction--on the paradigm changes in drug dependence treatment]T Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
ALTEX|January 1, 1993
[Problems of the prophylactic use of antibiotics in cell culture]Ingrid Kuhlmann
Clinical Pharmacology and Therapeutics|February 1, 1985
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxinJ Kuhlmann
Morphologie : Bulletin De L'Association Des Anatomistes|December 7, 2007
[The first ray of the hand and the foot of the primates (I). Descriptive anatomy]Norbert Kuhlmann
Cytotechnology|February 24, 2012
The prophylactic use of antibiotics in cell cultureI Kuhlmann
Journal of AOAC International|April 18, 2019
2-Monochloropropanediol (2-MCPD), 3-Monochloropropanediol (3-MCPD), and Glycidol in Infant and Adult/Pediatric Nutritional Formula: Single-Laboratory Validation, First Action 2018.12Jan Kuhlmann
Arzneimittel-Forschung|January 1, 1982
Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapyJ Kuhlmann
Pageof 249